Global Infantile Spasm Treatment Market Growth (Status and Outlook) 2025-2031

September 2025 | 99 pages | ID: G32994E33A2EN
LP Information

Abstracts

According to this study, the global Infantile Spasm Treatment market size will reach US$ 194 million by 2031.

An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Infantile Spasm Treatment Industry Forecast” looks at past sales and reviews total world Infantile Spasm Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Infantile Spasm Treatment sales for 2025 through 2031. With Infantile Spasm Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infantile Spasm Treatment industry.

This Insight Report provides a comprehensive analysis of the global Infantile Spasm Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Infantile Spasm Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Infantile Spasm Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infantile Spasm Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infantile Spasm Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Infantile Spasm Treatment market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Oral
• Parenteral

Segmentation by Application:

• Hospital
• Clinic
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Mallinckrodt
• H. Lundbeck
• Insys Therapeutics
• Orphelia Pharma
• Valerion Therapeutics
• Catalyst Pharmaceuticals
• Anavex Life Sciences
• Retrophin
• GW Pharmaceuticals

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Infantile Spasm Treatment Market Size (2020-2031)
  2.1.2 Infantile Spasm Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Infantile Spasm Treatment by Country/Region (2020, 2024 & 2031)
2.2 Infantile Spasm Treatment Segment by Type
  2.2.1 Oral
  2.2.2 Parenteral
2.3 Infantile Spasm Treatment Market Size by Type
  2.3.1 Infantile Spasm Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Infantile Spasm Treatment Market Size Market Share by Type (2020-2025)
2.4 Infantile Spasm Treatment Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Other
2.5 Infantile Spasm Treatment Market Size by Application
  2.5.1 Infantile Spasm Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Infantile Spasm Treatment Market Size Market Share by Application (2020-2025)

3 INFANTILE SPASM TREATMENT MARKET SIZE BY PLAYER

3.1 Infantile Spasm Treatment Market Size Market Share by Player
  3.1.1 Global Infantile Spasm Treatment Revenue by Player (2020-2025)
  3.1.2 Global Infantile Spasm Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Infantile Spasm Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 INFANTILE SPASM TREATMENT BY REGION

4.1 Infantile Spasm Treatment Market Size by Region (2020-2025)
4.2 Global Infantile Spasm Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Infantile Spasm Treatment Market Size Growth (2020-2025)
4.4 APAC Infantile Spasm Treatment Market Size Growth (2020-2025)
4.5 Europe Infantile Spasm Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Infantile Spasm Treatment Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Infantile Spasm Treatment Market Size by Country (2020-2025)
5.2 Americas Infantile Spasm Treatment Market Size by Type (2020-2025)
5.3 Americas Infantile Spasm Treatment Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Infantile Spasm Treatment Market Size by Region (2020-2025)
6.2 APAC Infantile Spasm Treatment Market Size by Type (2020-2025)
6.3 APAC Infantile Spasm Treatment Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Infantile Spasm Treatment Market Size by Country (2020-2025)
7.2 Europe Infantile Spasm Treatment Market Size by Type (2020-2025)
7.3 Europe Infantile Spasm Treatment Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Infantile Spasm Treatment by Region (2020-2025)
8.2 Middle East & Africa Infantile Spasm Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Infantile Spasm Treatment Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL INFANTILE SPASM TREATMENT MARKET FORECAST

10.1 Global Infantile Spasm Treatment Forecast by Region (2026-2031)
  10.1.1 Global Infantile Spasm Treatment Forecast by Region (2026-2031)
  10.1.2 Americas Infantile Spasm Treatment Forecast
  10.1.3 APAC Infantile Spasm Treatment Forecast
  10.1.4 Europe Infantile Spasm Treatment Forecast
  10.1.5 Middle East & Africa Infantile Spasm Treatment Forecast
10.2 Americas Infantile Spasm Treatment Forecast by Country (2026-2031)
  10.2.1 United States Market Infantile Spasm Treatment Forecast
  10.2.2 Canada Market Infantile Spasm Treatment Forecast
  10.2.3 Mexico Market Infantile Spasm Treatment Forecast
  10.2.4 Brazil Market Infantile Spasm Treatment Forecast
10.3 APAC Infantile Spasm Treatment Forecast by Region (2026-2031)
  10.3.1 China Infantile Spasm Treatment Market Forecast
  10.3.2 Japan Market Infantile Spasm Treatment Forecast
  10.3.3 Korea Market Infantile Spasm Treatment Forecast
  10.3.4 Southeast Asia Market Infantile Spasm Treatment Forecast
  10.3.5 India Market Infantile Spasm Treatment Forecast
  10.3.6 Australia Market Infantile Spasm Treatment Forecast
10.4 Europe Infantile Spasm Treatment Forecast by Country (2026-2031)
  10.4.1 Germany Market Infantile Spasm Treatment Forecast
  10.4.2 France Market Infantile Spasm Treatment Forecast
  10.4.3 UK Market Infantile Spasm Treatment Forecast
  10.4.4 Italy Market Infantile Spasm Treatment Forecast
  10.4.5 Russia Market Infantile Spasm Treatment Forecast
10.5 Middle East & Africa Infantile Spasm Treatment Forecast by Region (2026-2031)
  10.5.1 Egypt Market Infantile Spasm Treatment Forecast
  10.5.2 South Africa Market Infantile Spasm Treatment Forecast
  10.5.3 Israel Market Infantile Spasm Treatment Forecast
  10.5.4 Turkey Market Infantile Spasm Treatment Forecast
10.6 Global Infantile Spasm Treatment Forecast by Type (2026-2031)
10.7 Global Infantile Spasm Treatment Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Infantile Spasm Treatment Forecast

11 KEY PLAYERS ANALYSIS

11.1 Mallinckrodt
  11.1.1 Mallinckrodt Company Information
  11.1.2 Mallinckrodt Infantile Spasm Treatment Product Offered
  11.1.3 Mallinckrodt Infantile Spasm Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Mallinckrodt Main Business Overview
  11.1.5 Mallinckrodt Latest Developments
11.2 H. Lundbeck
  11.2.1 H. Lundbeck Company Information
  11.2.2 H. Lundbeck Infantile Spasm Treatment Product Offered
  11.2.3 H. Lundbeck Infantile Spasm Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 H. Lundbeck Main Business Overview
  11.2.5 H. Lundbeck Latest Developments
11.3 Insys Therapeutics
  11.3.1 Insys Therapeutics Company Information
  11.3.2 Insys Therapeutics Infantile Spasm Treatment Product Offered
  11.3.3 Insys Therapeutics Infantile Spasm Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Insys Therapeutics Main Business Overview
  11.3.5 Insys Therapeutics Latest Developments
11.4 Orphelia Pharma
  11.4.1 Orphelia Pharma Company Information
  11.4.2 Orphelia Pharma Infantile Spasm Treatment Product Offered
  11.4.3 Orphelia Pharma Infantile Spasm Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Orphelia Pharma Main Business Overview
  11.4.5 Orphelia Pharma Latest Developments
11.5 Valerion Therapeutics
  11.5.1 Valerion Therapeutics Company Information
  11.5.2 Valerion Therapeutics Infantile Spasm Treatment Product Offered
  11.5.3 Valerion Therapeutics Infantile Spasm Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Valerion Therapeutics Main Business Overview
  11.5.5 Valerion Therapeutics Latest Developments
11.6 Catalyst Pharmaceuticals
  11.6.1 Catalyst Pharmaceuticals Company Information
  11.6.2 Catalyst Pharmaceuticals Infantile Spasm Treatment Product Offered
  11.6.3 Catalyst Pharmaceuticals Infantile Spasm Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Catalyst Pharmaceuticals Main Business Overview
  11.6.5 Catalyst Pharmaceuticals Latest Developments
11.7 Anavex Life Sciences
  11.7.1 Anavex Life Sciences Company Information
  11.7.2 Anavex Life Sciences Infantile Spasm Treatment Product Offered
  11.7.3 Anavex Life Sciences Infantile Spasm Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Anavex Life Sciences Main Business Overview
  11.7.5 Anavex Life Sciences Latest Developments
11.8 Retrophin
  11.8.1 Retrophin Company Information
  11.8.2 Retrophin Infantile Spasm Treatment Product Offered
  11.8.3 Retrophin Infantile Spasm Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Retrophin Main Business Overview
  11.8.5 Retrophin Latest Developments
11.9 GW Pharmaceuticals
  11.9.1 GW Pharmaceuticals Company Information
  11.9.2 GW Pharmaceuticals Infantile Spasm Treatment Product Offered
  11.9.3 GW Pharmaceuticals Infantile Spasm Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 GW Pharmaceuticals Main Business Overview
  11.9.5 GW Pharmaceuticals Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Infantile Spasm Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Infantile Spasm Treatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Parenteral
Table 5. Infantile Spasm Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Infantile Spasm Treatment Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Infantile Spasm Treatment Market Size Market Share by Type (2020-2025)
Table 8. Infantile Spasm Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Infantile Spasm Treatment Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Infantile Spasm Treatment Market Size Market Share by Application (2020-2025)
Table 11. Global Infantile Spasm Treatment Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Infantile Spasm Treatment Revenue Market Share by Player (2020-2025)
Table 13. Infantile Spasm Treatment Key Players Head office and Products Offered
Table 14. Infantile Spasm Treatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Infantile Spasm Treatment Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Infantile Spasm Treatment Market Size Market Share by Region (2020-2025)
Table 19. Global Infantile Spasm Treatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Infantile Spasm Treatment Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Infantile Spasm Treatment Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Infantile Spasm Treatment Market Size Market Share by Country (2020-2025)
Table 23. Americas Infantile Spasm Treatment Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Infantile Spasm Treatment Market Size Market Share by Type (2020-2025)
Table 25. Americas Infantile Spasm Treatment Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Infantile Spasm Treatment Market Size Market Share by Application (2020-2025)
Table 27. APAC Infantile Spasm Treatment Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Infantile Spasm Treatment Market Size Market Share by Region (2020-2025)
Table 29. APAC Infantile Spasm Treatment Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Infantile Spasm Treatment Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Infantile Spasm Treatment Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Infantile Spasm Treatment Market Size Market Share by Country (2020-2025)
Table 33. Europe Infantile Spasm Treatment Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Infantile Spasm Treatment Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Infantile Spasm Treatment Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Infantile Spasm Treatment Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Infantile Spasm Treatment Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Infantile Spasm Treatment
Table 39. Key Market Challenges & Risks of Infantile Spasm Treatment
Table 40. Key Industry Trends of Infantile Spasm Treatment
Table 41. Global Infantile Spasm Treatment Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Infantile Spasm Treatment Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Infantile Spasm Treatment Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Infantile Spasm Treatment Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Mallinckrodt Details, Company Type, Infantile Spasm Treatment Area Served and Its Competitors
Table 46. Mallinckrodt Infantile Spasm Treatment Product Offered
Table 47. Mallinckrodt Infantile Spasm Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Mallinckrodt Main Business
Table 49. Mallinckrodt Latest Developments
Table 50. H. Lundbeck Details, Company Type, Infantile Spasm Treatment Area Served and Its Competitors
Table 51. H. Lundbeck Infantile Spasm Treatment Product Offered
Table 52. H. Lundbeck Infantile Spasm Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. H. Lundbeck Main Business
Table 54. H. Lundbeck Latest Developments
Table 55. Insys Therapeutics Details, Company Type, Infantile Spasm Treatment Area Served and Its Competitors
Table 56. Insys Therapeutics Infantile Spasm Treatment Product Offered
Table 57. Insys Therapeutics Infantile Spasm Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Insys Therapeutics Main Business
Table 59. Insys Therapeutics Latest Developments
Table 60. Orphelia Pharma Details, Company Type, Infantile Spasm Treatment Area Served and Its Competitors
Table 61. Orphelia Pharma Infantile Spasm Treatment Product Offered
Table 62. Orphelia Pharma Infantile Spasm Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Orphelia Pharma Main Business
Table 64. Orphelia Pharma Latest Developments
Table 65. Valerion Therapeutics Details, Company Type, Infantile Spasm Treatment Area Served and Its Competitors
Table 66. Valerion Therapeutics Infantile Spasm Treatment Product Offered
Table 67. Valerion Therapeutics Infantile Spasm Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Valerion Therapeutics Main Business
Table 69. Valerion Therapeutics Latest Developments
Table 70. Catalyst Pharmaceuticals Details, Company Type, Infantile Spasm Treatment Area Served and Its Competitors
Table 71. Catalyst Pharmaceuticals Infantile Spasm Treatment Product Offered
Table 72. Catalyst Pharmaceuticals Infantile Spasm Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Catalyst Pharmaceuticals Main Business
Table 74. Catalyst Pharmaceuticals Latest Developments
Table 75. Anavex Life Sciences Details, Company Type, Infantile Spasm Treatment Area Served and Its Competitors
Table 76. Anavex Life Sciences Infantile Spasm Treatment Product Offered
Table 77. Anavex Life Sciences Infantile Spasm Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Anavex Life Sciences Main Business
Table 79. Anavex Life Sciences Latest Developments
Table 80. Retrophin Details, Company Type, Infantile Spasm Treatment Area Served and Its Competitors
Table 81. Retrophin Infantile Spasm Treatment Product Offered
Table 82. Retrophin Infantile Spasm Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Retrophin Main Business
Table 84. Retrophin Latest Developments
Table 85. GW Pharmaceuticals Details, Company Type, Infantile Spasm Treatment Area Served and Its Competitors
Table 86. GW Pharmaceuticals Infantile Spasm Treatment Product Offered
Table 87. GW Pharmaceuticals Infantile Spasm Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. GW Pharmaceuticals Main Business
Table 89. GW Pharmaceuticals Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Infantile Spasm Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Infantile Spasm Treatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Infantile Spasm Treatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Infantile Spasm Treatment Sales Market Share by Country/Region (2024)
Figure 8. Infantile Spasm Treatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Infantile Spasm Treatment Market Size Market Share by Type in 2024
Figure 10. Infantile Spasm Treatment in Hospital
Figure 11. Global Infantile Spasm Treatment Market: Hospital (2020-2025) & ($ millions)
Figure 12. Infantile Spasm Treatment in Clinic
Figure 13. Global Infantile Spasm Treatment Market: Clinic (2020-2025) & ($ millions)
Figure 14. Infantile Spasm Treatment in Other
Figure 15. Global Infantile Spasm Treatment Market: Other (2020-2025) & ($ millions)
Figure 16. Global Infantile Spasm Treatment Market Size Market Share by Application in 2024
Figure 17. Global Infantile Spasm Treatment Revenue Market Share by Player in 2024
Figure 18. Global Infantile Spasm Treatment Market Size Market Share by Region (2020-2025)
Figure 19. Americas Infantile Spasm Treatment Market Size 2020-2025 ($ millions)
Figure 20. APAC Infantile Spasm Treatment Market Size 2020-2025 ($ millions)
Figure 21. Europe Infantile Spasm Treatment Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Infantile Spasm Treatment Market Size 2020-2025 ($ millions)
Figure 23. Americas Infantile Spasm Treatment Value Market Share by Country in 2024
Figure 24. United States Infantile Spasm Treatment Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Infantile Spasm Treatment Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Infantile Spasm Treatment Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Infantile Spasm Treatment Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Infantile Spasm Treatment Market Size Market Share by Region in 2024
Figure 29. APAC Infantile Spasm Treatment Market Size Market Share by Type (2020-2025)
Figure 30. APAC Infantile Spasm Treatment Market Size Market Share by Application (2020-2025)
Figure 31. China Infantile Spasm Treatment Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Infantile Spasm Treatment Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Infantile Spasm Treatment Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Infantile Spasm Treatment Market Size Growth 2020-2025 ($ millions)
Figure 35. India Infantile Spasm Treatment Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Infantile Spasm Treatment Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Infantile Spasm Treatment Market Size Market Share by Country in 2024
Figure 38. Europe Infantile Spasm Treatment Market Size Market Share by Type (2020-2025)
Figure 39. Europe Infantile Spasm Treatment Market Size Market Share by Application (2020-2025)
Figure 40. Germany Infantile Spasm Treatment Market Size Growth 2020-2025 ($ millions)
Figure 41. France Infantile Spasm Treatment Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Infantile Spasm Treatment Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Infantile Spasm Treatment Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Infantile Spasm Treatment Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Infantile Spasm Treatment Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Infantile Spasm Treatment Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Infantile Spasm Treatment Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Infantile Spasm Treatment Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Infantile Spasm Treatment Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Infantile Spasm Treatment Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Infantile Spasm Treatment Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Infantile Spasm Treatment Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Infantile Spasm Treatment Market Size 2026-2031 ($ millions)
Figure 54. APAC Infantile Spasm Treatment Market Size 2026-2031 ($ millions)
Figure 55. Europe Infantile Spasm Treatment Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Infantile Spasm Treatment Market Size 2026-2031 ($ millions)
Figure 57. United States Infantile Spasm Treatment Market Size 2026-2031 ($ millions)
Figure 58. Canada Infantile Spasm Treatment Market Size 2026-2031 ($ millions)
Figure 59. Mexico Infantile Spasm Treatment Market Size 2026-2031 ($ millions)
Figure 60. Brazil Infantile Spasm Treatment Market Size 2026-2031 ($ millions)
Figure 61. China Infantile Spasm Treatment Market Size 2026-2031 ($ millions)
Figure 62. Japan Infantile Spasm Treatment Market Size 2026-2031 ($ millions)
Figure 63. Korea Infantile Spasm Treatment Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Infantile Spasm Treatment Market Size 2026-2031 ($ millions)
Figure 65. India Infantile Spasm Treatment Market Size 2026-2031 ($ millions)
Figure 66. Australia Infantile Spasm Treatment Market Size 2026-2031 ($ millions)
Figure 67. Germany Infantile Spasm Treatment Market Size 2026-2031 ($ millions)
Figure 68. France Infantile Spasm Treatment Market Size 2026-2031 ($ millions)
Figure 69. UK Infantile Spasm Treatment Market Size 2026-2031 ($ millions)
Figure 70. Italy Infantile Spasm Treatment Market Size 2026-2031 ($ millions)
Figure 71. Russia Infantile Spasm Treatment Market Size 2026-2031 ($ millions)
Figure 72. Egypt Infantile Spasm Treatment Market Size 2026-2031 ($ millions)
Figure 73. South Africa Infantile Spasm Treatment Market Size 2026-2031 ($ millions)
Figure 74. Israel Infantile Spasm Treatment Market Size 2026-2031 ($ millions)
Figure 75. Turkey Infantile Spasm Treatment Market Size 2026-2031 ($ millions)
Figure 76. Global Infantile Spasm Treatment Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Infantile Spasm Treatment Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Infantile Spasm Treatment Market Size 2026-2031 ($ millions)